Recipharm named Vikas Gupta as President of its recently renamed biologics business arm. Gupta joins ReciBioPharm from Repligen, where he was Vice President & General Manager, Gene Therapy and Downstream Bioprocessing. The appointment comes as Recipharm officially renames its biologics business division after the acquisitions of Arranta Bio, GenIbet and Vibalogics.
1st Jan change | Capi. | |
---|---|---|
+7.91% | 72.94B | |
+12.64% | 9.06B | |
-10.56% | 5.07B | |
+58.79% | 4.78B | |
+4.07% | 3.9B | |
-16.90% | 2.56B | |
+20.84% | 2.42B | |
-26.13% | 2.39B | |
+19.31% | 2.18B |